EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections

Gagandeep Singh, Anass Abbad, Johnstone Tcheou, Demodara Rao Mendu, Adolfo Firpo-Betancourt, Charles Gleason, Komal Srivastava, Carlos Cordon-Cardo, Viviana Simon, Florian Krammer iD, Juan Manuel Carreño

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiad116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Gagandeep Singh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, Antibody Affinity, Breakthrough Infections, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, Department of Health and Human Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The number of exposures to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to vaccine antigens affect the magnitude and avidity of the polyclonal response.

Methods

We studied binding and avidity of different antibody isotypes to the spike, the receptor-binding domain (RBD), and the nucleoprotein (NP) of wild-type (WT) and BA.1 SARS-CoV-2 in convalescent, mRNA vaccinated and/or boosted, hybrid immune individuals and in individuals with breakthrough cases during the peak of the BA.1 wave.

Results

We found an increase in spike-binding antibodies and antibody avidity with increasing number of exposures to infection and/or vaccination. NP antibodies were detectible in convalescent individuals and a proportion of breakthrough cases, but they displayed low avidity. Omicron breakthrough infections elicited high levels of cross-reactive antibodies between WT and BA.1 antigens in vaccinated individuals without prior infection directed against the spike and RBD. The magnitude of the antibody response and avidity correlated with neutralizing activity against WT virus.

Conclusions

The magnitude and quality of the antibody response increased with the number of antigenic exposures, including breakthrough infections. However, cross-reactivity of the antibody response after BA.1 breakthroughs, was affected by the number of prior exposures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralAntibody AffinityBreakthrough InfectionsCOVID-19SARS-CoV-2AnimalsHumansChlorocebus aethiopsCOVID-19 Serological TestingVaccinationVero CellsBNT162 Vaccine

Stichwörter der Autor:innen

SARS-CoV-2antibodiesavidityneutralizationomicron

Substanzen

Antibodies, ViralBNT162 Vaccine

Autor:innen und Institutionen

  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Florian Krammer

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • Department of Health and Human Service

Zitieren

APA

Singh, G., Abbad, A., Tcheou, J., Mendu, D. R., Firpo-Betancourt, A., Gleason, C., Srivastava, K., Cordon-Cardo, C., Simon, V., Krammer, F., & Carreño, J. M. (2023). Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad116

Vancouver

Singh G, Abbad A, Tcheou J, Mendu DR, Firpo-Betancourt A, Gleason C, et al. Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad116

BibTeX
@article{Singh2023,
  author = {Singh, Gagandeep and Abbad, Anass and Tcheou, Johnstone and Mendu, Demodara Rao and Firpo-Betancourt, Adolfo and Gleason, Charles and Srivastava, Komal and Cordon-Cardo, Carlos and Simon, Viviana and Krammer, Florian and Carreño, Juan Manuel},
  title = {Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiad116}
}
Kostenlos starten →